Renewal of Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Product: Amyl Nitrite Inhalant. Active Ingredient(s): Amyl nitrite 98% w/v. Dosage Form: Volatile liquid for inhalation. NZ Sponsor: Baxter Healthcare Limited. Manufacturer(s): Newton Industries Inc, Newton, New Jersey, United States of America. Note: This consent is valid for 2 years from 17 April 1999. Dated this 22nd day of July 1999. G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).